Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences shares fell to the mid-$15 range on December 18, 2025, following a volatile period sparked by positive Phase 1 data for its obesity drug candidate WVE-007 and a large equity offering. No new announcements drove the move; trading reflected continued volatility after the early December clinical data and financing. Analysts remain bullish, but dilution and early-stage risk weigh on the stock.
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals shares fell about 8% Thursday after a regulatory filing disclosed Chief Medical and Development Officer Dr. Dana Pizzuti will step down December 31. She will transition to a Strategic Regulatory and Development Advisor role in early 2026. The stock traded in the low-to-high $40s as investors reacted to the leadership change.
18 December 2025
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock shares fell 8% to $42.58 on Dec. 18 after the company posted record fiscal 2025 revenue of €2.1 billion and strong profit growth but issued cautious 2026 guidance citing tariff and currency pressures. The stock swung between $39.73 and $46.75 in heavy trading as investors reacted to margin concerns despite robust recent results.
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics shares fell 8.8% to $20.35 on Thursday, with no new company news released that day. The stock traded between $20.33 and $22.81 on volume of about 1.25 million shares. EWTX remains 38% below its 52-week high and 92% above its 52-week low. The company’s recent updates include a December stock option grant and a November board appointment.
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries shares fell 10.6% Thursday to $43.13 after reporting adjusted Q4 EPS of $0.88, missing consensus, though revenue rose 5.4% to $2.295 billion, beating estimates. The company cited a $0.26 per-share hit from self-insurance adjustments and announced a $275 million acquisition. UBS downgraded the stock, citing margin and leverage concerns.
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems shares fell sharply on December 18, 2025, after two Medicare contractors, CGS and Noridian, pulled CPT code 64568 for hypoglossal nerve stimulation and redirected billing to CPT 64582. The move cast doubt on a key reimbursement upgrade that had driven recent stock gains, sending INSP down in the mid-to-high teens by early afternoon.
18 December 2025
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed shares fell 16% Thursday after the company said its Phase 2b trial of brensocatib in chronic rhinosinusitis without nasal polyps failed to meet endpoints, prompting it to end development for that indication. The drug’s performance matched or trailed placebo on symptom scores. Insmed reported no new safety issues. The stock traded near $166.75 after hitting a low of $158.06.
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings shares rose about 8% to near $49 on December 18 after Technology Credit Union announced it will use Upstart’s AI platform for personal and auto refinance loans. Tech CU began lending through Upstart’s network in September. Trading volume was below average despite the price jump. Analyst sentiment on the stock remains split.
18 December 2025
ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

Valletta / Brussels / Barcelona — December 18, 2025.Across Europe today, three storylines converged around the same theme: predictability—who can offer it, who needs it, and how much it costs. In Brussels, EU leaders entered what diplomats described as a make-or-break summit over a proposed €90 billion “reparations loan” for Ukraine, backed by profits from frozen Russian central bank assets—a plan that has exposed deep legal and financial anxieties inside the bloc. Reuters+2The Guardian+2 In the Mediterranean, Malta is leaning hard into the opposite narrative: a small jurisdiction selling stability at scale. On the same day, GamingMalta detailed how it
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies shares rose 6.83% to $29.88 on December 18 after Bank of America raised its price target to $37 and the U.S. Department of Transportation announced a national strategy for advanced air mobility. The stock, which debuted in November at $34 per share, touched an intraday high of $30.49. Trading volume was lighter than usual.
18 December 2025
Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (NYSE: KRMN) rose nearly 6% to $68.93 on December 18 after an SEC filing showed Oak Thistle LLC bought 24,538 shares valued at $1.77 million in Q3. The stock traded between $67.04 and $70.88 during the session and holds a market cap near $8.6 billion. Karman supplies subsystems for space and defense programs and reports over 80 customers across 130 projects.
18 December 2025
Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital shares rose about 7.4% to $23.63 midday December 18 after announcing a development loan facility with Macquarie Group. The $100 million facility, secured via subsidiary APLD DevCo LLC, will fund early-stage work on new data center projects. The company said it is in advanced talks with an investment-grade hyperscaler for multiple campuses. Trading volume was heavy following the financing news.
18 December 2025
Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries delivered the first truckload of ore to the run-of-mine pad at its Sangdong Tungsten Mine in South Korea, marking a shift from construction to mining operations. Shares on NASDAQ rose about 8.7% to $8.52 with heavy volume. The company positions Sangdong as a strategic supply source amid global efforts to reduce reliance on Chinese tungsten.
Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources shares jumped about 8% to $90 Thursday after the company announced the restart of longwall mining at its Leer South mine in West Virginia. Operations had been suspended since January due to combustion-related issues. The company also reported stable productivity at its West Elk mine in Colorado following a seam transition. Management expects Leer South to be fully ramped by early 2026.
18 December 2025
Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab launched the STP‑S30 mission for the U.S. Space Force five months ahead of schedule, deploying four DiskSat spacecraft from Virginia early Thursday. Shares rose in midday trading, reaching the mid‑$50s. The mission marked Rocket Lab’s 20th Electron launch in 2025 and its 78th overall. DiskSat, a NASA-backed tech demo, aims to test a new smallsat form factor.
Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

Banco BBVA Argentina ADS (BBAR) surged 8.7% to $18.44 in New York trading, following news of a new dividend, an auto-finance deal, and upcoming changes to Argentina’s currency regime. The central bank will index the peso’s exchange-rate band to inflation starting January 1, 2026, replacing the previous fixed adjustment.
18 December 2025
India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

India’s Parliament passed the SHANTI Bill on December 18, 2025, opening the civil nuclear sector to private Indian companies and joint ventures for the first time. Opposition parties and unions announced nationwide protests, citing safety and liability concerns. The law replaces two key nuclear acts and aims to boost nuclear capacity to 100 GW by 2047. Foreign firms can participate only through partnerships with Indian companies.
18 December 2025
1 373 374 375 376 377 535

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop